"At Aptar Pharma, the patient remains at the center of everything we do," said Craig Baker, President of Noble, an Aptar Pharma company. AI-Driven Feedback from SoundThe patented approach uses time-series acoustic sensing and neural network-based machine learning to analyze device-generated sound signatures and determine whether a drug delivery or diagnostic device has been operated correctly. The patient remains the common thread throughout this journey, from early-stage formulation and device development through successful therapy administration and long-term adherence. About NobleNoble is part of the Aptar Pharma segment of AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies. Noble provides patient-centered solutions that support the safe and effective use of drug delivery and diagnostic devices across the therapy lifecycle.